| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09ca043d7e596facff1f44b746e2f4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bba0a34651fd8cd73cf83e6a9effe12 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24134 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
| filingDate |
2009-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a03aa56dedef80c1eaf8f2294864e4da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf578d41a2928e2560413cc584e1eb2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_402276edd4cf79694b1198e720ed408b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d27b3f23fb19c442ae5bb13f3d8bda6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64b96f679759dc879ead2cab449b64b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80bbbd8bb545d3e2690c391dcccf7a23 |
| publicationDate |
2011-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20110036907-A |
| titleOfInvention |
Method for raising the potency of Japanese encephalitis virus antigen by microneedle device and microneedle device |
| abstract |
Provided is a method for enhancing immunogenicity by a microneedle device that enhances immunogenicity of Japanese encephalitis virus antigens. The method for enhancing immunogenicity by the microneedle device is to transdermally administer Japanese encephalitis virus antigens using microneedles coated with Japanese encephalitis virus antigens consisting of antigens derived from monkey kidney cells (Vero cells). The antibody of the viral antigen rises. After the transdermal administration of the microneedles coated with the Japanese encephalitis virus antigen, a patch containing lauryl alcohol is attached. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160124646-A |
| priorityDate |
2008-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |